Kimberly Manhard

2021

In 2021, Kimberly Manhard earned a total compensation of $1.9M as Executive Vice President, Drug Development at Heron Therapeutics, a 15% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$205,975
Option Awards$535,147
Salary$514,937
Stock Awards$583,626
Other$18,893
Total$1,858,578

Manhard received $583.6K in stock awards, accounting for 31% of the total pay in 2021.

Manhard also received $206K in non-equity incentive plan, $535.1K in option awards, $514.9K in salary and $18.9K in other compensation.

Rankings

In 2021, Kimberly Manhard's compensation ranked 6,330th out of 12,415 executives tracked by ExecPay. In other words, Manhard earned more than 49.0% of executives.

ClassificationRankingPercentile
All
6,330
out of 12,415
49th
Division
Manufacturing
2,695
out of 5,505
51st
Major group
Chemicals And Allied Products
1,183
out of 2,375
50th
Industry group
Drugs
1,053
out of 2,096
50th
Industry
Pharmaceutical Preparations
763
out of 1,546
51st

Pay ratio

Kimberly Manhard's Pay$1,858,578
Median Employee's Pay$268,692
Pay Ratio

7

to 1

In 2021, the annual total compensation of Kimberly Manhard was $1,858,578.

The annual total compensation of the median employee at Heron Therapeutics was $268,692.

The ratio of Kimberly Manhard's pay to the pay of median employee was therefore 7 to one.

Source: SEC filing on April 25, 2022.

Manhard's colleagues

We found four more compensation records of executives who worked with Kimberly Manhard at Heron Therapeutics in 2021.

2021

Barry Quart

Heron Therapeutics

Chief Executive Officer

2021

John Poyhonen

Heron Therapeutics

President and Chief Commercial Officer

2021

David Szekeres

Heron Therapeutics

Chief Operating Officer

2021

Lisa Peraza

Heron Therapeutics

Chief Accounting Officer

News

You may also like